Iotalamic acid

Iotalamic acid
Skeletal formula of iotalamic acid
Space-filling model of the iotalamic acid molecule
Clinical data
Trade namesConray, others
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
IUPAC name
  • 3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.017.181 Edit this at Wikidata
Chemical and physical data
FormulaC11H9I3N2O4
Molar mass613.91357 g·mol−1
3D model (JSmol)
SMILES
  • CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I
InChI
  • InChI=1S/C11H9I3N2O4/c1-3(17)16-9-7(13)4(10(18)15-2)6(12)5(8(9)14)11(19)20/h1-2H3,(H,15,18)(H,16,17)(H,19,20)
  • Key:UXIGWFXRQKWHHA-UHFFFAOYSA-N

Iotalamic acid (USAN: iothalamic acid, trade name Conray) is an iodine-containing radiocontrast agent. It is available in form of its salts, sodium iotalamate and meglumine iotalamate. It can be given intravenously or intravesically (into the urinary bladder).[1]

A radioactive formulation is also available as sodium iothalamate I-125 injection (trade name Glofil-125). It is indicated for evaluation of glomerular filtration in the diagnosis or monitoring of patients with renal disease.[2]

References

  1. ↑ "Conray". www.drugs.com. Retrieved 2021-03-30.
  2. ↑ "Glofil-125". www.drugs.com. Retrieved 2021-03-30.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.